宝ホ
ン
連結
Takara Holdings Inc. ‐Consolidated‐要約損益計算書
Consolidated Statements of Income by Business Group (Summary)
要約
借対照表
Consolidated Balance Sheets (Summary)
宝酒造
Takara Shuzo Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)成
期
決算短信補足資料
Supplement for the Consolidated Financial Statements for the Year Ended March 31, 2009
タ
バ
Takara Bio Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)事業
種類
セ
メン
情報
Industry Segments Information
売
高及び営業損益
Sales and Operating Income資産
減価償却費
減損損失及び資本的支出
Assets, Depreciation, Impairment loss and Capital Expenditures.
成
期 業績
想
Financial forecast for the year ending March 31, 2010
宝ホ
ン
連結
Takara Holdings Inc. ‐Consolidated‐
宝酒造
Takara Shuzo Group
タ
バ
Takara Bio GroupIR
Investor Relations Office
TEL 075(241)5124
FAX 075(241)5127
E M il i @t k
j
IR
Investor Relations Office
将来見通
関す
注意事項
資料中
当社
び当社
現
計画
見通
戦略
確信
う
歴史的事実
いも
将来
業績
関す
見通
あ
現時
い
入手可能
情報
得
当社経営
断
基
くも
す
重大
や
確実性
含
い
情報
得
多く
仮定
び考え
基
も
あ
す
実際
業績
要素
測
大
く異
結果
得
知
く
い
実際
業績
影響
え
要素
経済情勢
特
消費動向
替
変動
法律
行政制度
変化
競合会社
価格
製品戦略
力
当社
既存製品
び新製品
販売力
生産中断
当社
知
的所
権
対す
侵害
急速
術革新
重大
訟
け
利
決等
あ
す
業績
影響
え
要素
限定
も
あ
せ
宝ホ
ルディングス株式会社
IR室
Takara Holdings Inc. Investor Relations Office.
T
7
X
7
7
I
r
ta
ara c
Forward-Looking Statements
Statements in this document, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions derived from information that includes major risks and uncertainties. Actual results may vary significantly from these forecasts due to various factors.
宝ホ
ン
連結
:Takara Holdings Inc. ‐Consolidated‐要約損益計算書
:Consolidated Statements of Income by Business Group (Summary)百万 :Millions of Yen
成 期
FY2008
実績 想 実績 増減 比 増減 比
Actual Forecast announced Nov.2008 Actual change % difference % 宝酒造
タ バ
そ 他
売 高
売 原価
売 総利益
運 費 保管料
広告 伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
宝酒造
タ バ
そ 他
成 期 対前期 対 想
ᇞ 40 95.9%
1,000
ᇞ 392
ᇞ 456
ᇞ 170
101.4%
Takara Shuzo Group
Cost of sales Gross profit Other,net Takara Bio Group
Net sales
Change from FY2008 Change from forecast anounced Nov.2008 FY2009 / April 1, 2008-March 31, 2009
191,878
74,900
117,864 985 100.8%
195,400 120,500 74,014 99.0% 100.5% 912 192,790 95.1%
ᇞ 1,698
ᇞ 636
SG&A expenses Takara Shuzo Group Takara Bio Group Other,net
Transportation and storage
Other,net Advertising
Sales promotion and allowance for s.p. 販売 進費 販売 進引当金繰入
Research and development
7,177 30,100 3,800 21,300 65,507 200 768 560 7,500
ᇞ 1,109 98.3%
66,200 99.4%
104.0%
191 124.9%
959
ᇞ 34 99.5%
426 ᇞ 133 76.2% 226 213.3%
7,465 287
65,090
57
ᇞ 300
98.7%
118,849
73,941 ᇞ 72 99.9%
101.1%
91.8%
98.0%
98.7% 94.3%
ᇞ 1,650
ᇞ 274
ᇞ 2,609
97.9%
ᇞ 958
6,851 272 104.1%
ᇞ 417 334
ᇞ 299
ᇞ 423
96.7% 166,788
20,278
4,811 4,575
2,513
ᇞ 1,364
18,913
171,000
19,550
4,850 ᇞ 235
169,301
98.7%
99.2% 88.0%
ᇞ 148
4,057 98.6% 101.5% 93.3% 7,000 4,000 6,578 4,358 29,373 3,643 21,553 29,707 3,343 21,129 93.1%
営業利益 △:損失
利息 郤当金
そ 他営業外収益 Other,net
営業外収益
支払利息
そ 他営業外費用 Other,net
営業外費用
経常利益 △:損失
特 利益
特 損失
法人税 民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額 形 無形
減価償却費 形 無形
営業外収益 利息 郤当金 託研究補助金
Non-operating income Interest income 342, Dividend income 428, Grant received for R&D 19, etc.
営業外費用 支払利息 社債利息 替差損
Non-operating expenses Interest expense 281, Bond interest 325, Foreign currency exchange losses 438, etc.
特 利益 固定資産売却益
Extraordinary gain Gain on sales of property, plant and equipment 700, etc.
104.0%
719 700 771 51 71 110.2%
1,010 300 312 ᇞ 698 12
107.2%
30.9%
Net income(△:loss) Other,net
当期純利益 △:損失 Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes Interest and discounts expenses Non-operating income
Non-operating expenses
Ordinary income(△:loss) Operating income(△:loss) Interest income Dividends income
252 ᇞ 17 93.5%
税金等調整前当期純利益△:損失
Minority interests in net income△:loss
Income(△:loss) before income taxes and minority interests
152 252.6%
100
ᇞ 598 79.3%
2,900
559 600 606 47 108.5% 101.1%
554 400 626
ᇞ 1,774 ᇞ 1,368 -
ᇞ 405
4,075 276 107.3%
3,798
ᇞ 6 99.9%
8,200 2,391
1 100.0%
8,700
769 ᇞ 820
ᇞ 122 91.2%
1,400
8,193 ᇞ 128 98.5%
1,277 ᇞ 1,114 53.4% 48.4%
1,590 ᇞ 130 85.5%
104.1%
72 113.1% 226 156.6%
6 83 108.3% 1,000 4,658 1,730 8,506 9,123 8,321 270 1,000 1,113 900 8,700
5,200 5,639 981 121.1%
233
1,083 ᇞ 647
439 108.5%
62.6%
123.3%
8,701 ᇞ 422 95.4%
151 101.7%
1,233 120 110.8%
8,851 345
ᇞ 125 97.6%
5,200
Depreciation 5,455 5,074 ᇞ 381 93.0%
ᇞ 383 90.4%
4,000
Capital expenditures 3,852 3,616 ᇞ 235 93.9%
特 損失 和解費用 固定資産売却 却損 投資 価証券評価損 減損損失 卸資産評価損
Extraordinary loss Loss on settlement payment of lawsuite 128, Loss on disposals of property, plant and equipment 208, Loss on write-down of investment securities 524, Impairment loss 229, Loss on valuation of inventories 95, etc.
要約
借対照表
:Consolidated Balance Sheets (Summary)資産の部
:Assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2008 FY2009 change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
Cash and deposits
手形及び売掛金
価証券
TH△ etcMarketable securities
卸資産
TS△ etcInventories
そ
他
Other current assets
倒引当金
Allowance for doubtful accounts
固定資産
(Total fixed assets)
形固定資産
当期 形 無形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible assets
建物及び構築物
新規 得 + TS+ TB+ etcBuildings and structures N l h +36 1
Notes and accounts receivable-trade, net
116,728
120,796
ᇞ
4,067
25,596
26,529
ᇞ
932
46,307
46,990
ᇞ
682
16,350
18,132
ᇞ
1,781
23,734
25,096
ᇞ
1,361
4,830
4,209
621
ᇞ
91
ᇞ
160
68
74,063
87,047
ᇞ
12,983
44,045
47,341
ᇞ
3,296
15 745
16 387
ᇞ
642
Buildings and structures Newly purchases +36.1
機械装置及び運搬具
減価償却 △ TS△ TB△ etcMachinery, equipment and vehicles Depreciation △50.7
土地
そ 他増減 △ 替差△ etcLand Other,net △39.1(Foreign currency exchange loss △14.7 etc.)
そ
他
Other property, plant and equipment
無形固定資産
Intangible fixed assets
投資そ
他
資産
Investments and other assets
投資
価証券
TH△ TB△ etcInvestment securities (TH Write-down loss △71.1, Impairment loss △4.7 etc.)
そ
他
Other assets
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
TH
=
Takara Holdings Inc. TS
=
Takara Shuzo Group TB
=
Takara Bio Group
15,745
16,387
ᇞ
642
11,509
13,059
ᇞ
1,550
13,511
14,547
ᇞ
1,036
3,279
3,345
ᇞ
65
ᇞ
2,077
25,534
33,144
ᇞ
7,610
18,429
26,122
ᇞ
7,692
4,484
6,561
190,792
207,843
ᇞ
17,051
7,372
7,427
ᇞ
54
ᇞ
268
ᇞ
405
136
要約
借対照表
:Consolidated Balance Sheets (Summary)
負債及び純資産
の部
:Liabilities and net assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2008 FY2009 change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
Notes and accounts payable-trade
短期借入金
Short-term loans payable
1
償還
社債
TH△ MayCurrent portion of bonds
未払酒税
Accrued alcohol tax
未払費用
Accrued expenses
販売
進引当金
そ
他
Other current liabilities
固定負債
(Total non-current liabilities)
社債
Bonds payable
長期借入金
Long-term loans payable
職給付引当金
TS+ etcReserve for retirement benefits
預
金
TS△Deposits from customers
そ
他
TH繰延税金負債 Deferred tax liabilities △ etcOther non-current liabilities
負債合計
Total liabilities
資本金
Capital stock
資本剰余金
Capital surplus
利益剰余金
Retained earnings
自己株式
TH自己株式 得 Purchase of treasury stock △ etcTreasury stock (3,500,000shares)
株主資本
(Total owner's equity)
そ
他
価証券評価差額金
TH△ etc繰延
ッ
損益
替換算調整勘定
TS△ TB△ etc評価
換算差額等
少数株主持分
(Minority interests)
純資産合計
Net assets
負債純資産合計
Total liabilities and net assets
TH
=
Takara Holdings Inc. TS
=
Takara Shuzo Group TB
=
Takara Bio Group
105,316
113,273
ᇞ
7,956
190,792
207,843
ᇞ
17,051
7,208
ᇞ
8,246
12,222
13,303
ᇞ
1,081
ᇞ
1,037
Reserve for sales promotion expenses13,226
13,226
-
85,475
94,570
ᇞ
9,095
6,464
6,639
ᇞ
174
5,548
5,718
ᇞ
169
9,093
8,899
193
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
(Total valuation and translation adjustments)
1,370
94,131
92,761
ᇞ
3,358
575
ᇞ
46
27
2,340
6,679
ᇞ
4,339
ᇞ
19
ᇞ
3,933
3,576
ᇞ
3,212
ᇞ
1,011
ᇞ
2,200
2,209
5,705
ᇞ
3,495
3,198
3,204
ᇞ
5
80,918
77,342
43,317
46,963
ᇞ
3,646
20,000
20,000
-
1,444
1,466
ᇞ
21
9,784
9,614
169
7,902
7,784
117
3,544
4,475
ᇞ
931
5,062
4,964
97
0
5,000
ᇞ
5,000
42,158
47,607
ᇞ
5,449
14,420
14,301
119
宝酒造
:Takara Shuzo Group要約損益計算書
:Statements of Income (Summary)百万 :Millions of Yen
成
期
FY2008
実績
想
実績
増減 比 増減 比Actual Forecast announced Nov.2008 Actual change % difference %
焼郥
清酒
ソフ
コ
飲料
そ
他酒類
本
そ
他調味料
原料用
コ
等
そ
他
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
6,064
11,800
Other 11,438 ᇞ 38
104,818
171,000
108,400
6,276
11,400
99.7% ᇞ 39961,970 ᇞ 425
ᇞ 1,272 102.2%
101.5% 97.6%
16,071 ᇞ 611
2,309 2,513
103.5% 4,900
ᇞ 123
96.2% 16,300
Hon Mirin
105.4% 5,554
成
期
383
ᇞ 438
対前期 対 想
ᇞ 43 99.3% 5,900
ᇞ 154 97.2% 5,600
Raw alcohol
5,445
545 111.1%104.2%
FY2009(April 1, 2008 - March 31, 2009) Change from FY2008 Change from forecast anounced Nov.2008
ᇞ 1,216
635
10,997
ᇞ 43494.9% 20,800 3,103 100.5% 76,400 23,000 96.2%
20,569
98.9% 98.1%ᇞ 202
ᇞ 230
103.2%
169,301
11,200 99.0%15,688
98.2% 96.6% 99.3%62,174
203 100.3%5,856
301ᇞ 383
98.8%
ᇞ 1,698
98.1%
103.5% 126
ᇞ 269
6,400
3,600 93.3%
212 Transportation and storage
Advertising
販売
進費
販売
進引当金繰入
3,995
3,726
Shochu
Cost of sales Gross profit Light-alcohol refreshers Sake Net sales Other liquors Other seasonings 73,679 23,777 19,934
76,783
22,561
166,788 11,432 62,600107,127
研究開発費
商標使用料
管理費
そ
他
販売費及び一般管理費
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
102.3% 318
License for use of trademarks 1,500
99.7% 3,600
Depreciation 3,890
3,588
ᇞ 302 92.2% ᇞ 11ᇞ 220 91.5% 2,600
Capital expenditures 2,229
2,379
149 106.7%77 117 211.1%
106.4% 97.4%
21
436
ᇞ 213 67.2%457
98.9%
99.8% 88.6%
ᇞ 45
ᇞ 23
ᇞ 328
100.2% 3
ᇞ 382
33
3,607 ᇞ 152
7,177
3,747
139.0% 100.7%
ᇞ 76
54,709
1,502
2101.0%
ᇞ 63
7,500
7,465
500
521
ᇞ 4349 92.3%
101.1%
96.1% 3,900
ᇞ 390 99.3%
55,100 99.8%
140 103.9%
87.3%
ᇞ 83
99.5%
ᇞ 34
287 104.0% 7,500
104.2%
127.2% 200
341 -
54
254
8 103.6%245
3,471
38 101.1%74.6% 300
277
46 119.9%231
ᇞ 6 99.8% 3,500
98.6% 7,600
3,433
7,495
528 107.6% ᇞ 10421
Non-operating incomeNon-operating expenses
Ordinary income(△:loss)
Other,net
Sales promotion and allowance for s.p.
販売
進費
販売
進引当金繰入
Operating income(△:loss) Research and development
ᇞ 319
200
223
105 650 54,792 28,052 350 28,700 400 14,500 1,469 6,966 7,092 500 14,858 56414,476
7,549
28,371
354
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss Income(△:loss) before income taxes and minority interests
要約
借対照表
:Balance Sheets (Summary)資産の部
:Assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2008 FY2009 change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
Cash and deposits
手形及び売掛金
価証券
Marketable securities
卸資産
宝酒造△ マ チン△ etcInventories Takara Shuzo △4.0, The Tomatin Distillery △11.0 etc.
そ
他
繰延税金資産 (Deferred tax assets) △ etcOther current assets
倒引当金
Allowance for doubtful accounts
固定資産
(Total fixed assets)
形固定資産
当期 形 無形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible assets
建物及び構築物
新規 得 +Buildings and structures N l h +23 7
Notes and accounts receivable-trade, net
29,332
30,570
ᇞ
1,237
11 140
11 852
ᇞ
712
ᇞ
40
ᇞ
45
4
36,999
38,501
ᇞ
1,502
20,208
21,614
ᇞ
1,405
3,576
3,935
ᇞ
358
40,873
40,515
358
3,801
3,821
ᇞ
19
77,609
78,595
ᇞ
985
9,190
8,755
435
Buildings and structures Newly purchases +23.7
機械装置及び運搬具
減価償却 △Machinery, equipment and vehicles Depreciation △35.8
土地
そ 他増減 △Land Other,net △5.0
そ
他
Other property, plant and equipment
無形固定資産
Intangible fixed assets
投資そ
他
資産
Investments and other assets
投資
価証券
Investment securities
そ
他
繰延税金資産 (Deferred tax assets) + etcOther assets
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
117,097
114,608
ᇞ
2,488
4,279
4,245
34
ᇞ
144
ᇞ
237
92
6,218
6,009
208
2,083
2,001
81
1,625
1,154
470
1,447
1,921
ᇞ
473
9,404
10,600
ᇞ
1,196
7,163
6,962
200
11,140
11,852
ᇞ
712
要約
借対照表
:Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2008 FY2009 change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
宝酒造 (Takara Shuzo) △ etcNotes and accounts payable-trade
短期借入金
Short-term loans payable
未払酒税
Accrued alcohol tax
未払費用
宝酒造 (Takara Shuzo) △ etcAccrued expenses
販売
進引当金
そ
他
Other current liabilities
固定負債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付引当金
Reserve for retirement benefits
預
金
宝酒造 引保証金返還Deposits from customers Takara Shuzo Repayments of guarantee deposits received
そ
他
繰延税金負債 (Deferred tax liabilities) + etcOther non-current liabilities
負債合計
Total liabilities
資本金
Capital stock
資本剰余金
Capital surplus
利益剰余金
Retained earnings
株主資本
(Total owner's equity)
そ
他
価証券評価差額金
繰延
ッ
損益
替換算調整勘定
評価
換算差額等
少数株主持分
(Minority interests)
純資産合計
Net assets
負債純資産合計
Total liabilities and net assets
3,130
7,440
7,495
ᇞ
54
3,293
ᇞ
163
1,444
2,035
2,738
ᇞ
702
114,608
117,097
ᇞ
2,488
67,755
69,864
ᇞ
2,109
68,060
67,062
998
ᇞ
19
ᇞ
46
27
31,962
32,593
ᇞ
630
11,257
11,813
ᇞ
555
787
740
47
7,902
7,784
117
1,466
ᇞ
21
14,891
14,639
251
92
116
ᇞ
24
46,853
47,232
ᇞ
378
7,720
7,605
115
6,434
6,609
ᇞ
174
(Total valuation and translation adjustments)
91
32
58
ᇞ
2,341
63
ᇞ
2,413
78
ᇞ
2,491
ᇞ
2,405
998
Reserve for sales promotion expensesValuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
10,382
9,384
1,000
1,000
-
56,678
56,678
-
643
307
336
タ
バ
:Takara Bio Group要約損益計算書
:Statements of Income (Summary)百万 :Millions of Yen
成
期
FY2008
実績
想
実績
増減 比 増減 比Actual Forecast announced Jan.2009 Actual change % difference %
研究用試薬
理化学機器
託
そ
他フ
ン
遺伝子工学研究
計
遺伝子医療
医食品バ
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
研究開発費
商標使用料
Research reagents
Cost of sales Gross profit
Contracted service and other Scientific instruments
Transportation and storage Advertising
Sales promotion
販売
進費
12,692
152 16,895 Genetic engineering research segment
165
ᇞ 63Gene medicine segment 72.3%
103.1% 101.7%
92.6% 291
53
1,131
3,214 ᇞ 320 ᇞ 238
96
84.0% 9,011
229 13 109.0%
2 90.3% 99.6% 148.7%
50
1,149
102.4% 82 104.3%
ᇞ 1,364
9,968
8,973
9,940
2,014
4618,913
ᇞ 66ᇞ 37
ᇞ 9
34
ᇞ 3
18
100.8%
93.8%
ᇞ 28 99.7%
Agribio segment 1,968
294
2,976
60
1,115
3,296 Research and development
Net sales 93.3%
対前期 対 想
FY2009(April 1, 2008 - March 31, 2009) Change from FY2008 Change from forecast anounced Jan.2009
1,932
81.9%
100.3% 11,870
2,359
成
期
35
ᇞ 182
11,906
2,177
93.8%
ᇞ 161
16,733
ᇞ 1,347ᇞ 785
ᇞ 480
ᇞ 81 97.0% ᇞ 15 99.4%
197 92.3% 10,223 20,278 18,080 99.7% 99.0% 2,657 2,730 92.5% 2,665 18,980
2,649
ᇞ 283 97.2%
10,055 ᇞ 1,081 89.2%
商標使用料
管理費
そ
他
販売費及び一般管理費
遺伝子医療
医食品バ
共通
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
36 -
ᇞ 1,612
Eliminations/Corporate ᇞ 1,607
ᇞ
1,576
30 --
ᇞ 1,400
98 -
ᇞ 673
159
ᇞ
1,240
ᇞ 20 -Agribio segment ᇞ 782
ᇞ
575
206 -Other,net
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss Income(△:loss) before income taxes and minority interests Non-operating income
Non-operating expenses
Ordinary income(△:loss)
Operating income(△:loss)
Genetic engineering research segment Gene medicine segment
100.0% 3
ᇞ 406 -
ᇞ 139
ᇞ
856
246
ᇞ 592 -
0
3
ᇞ 6 32.8%9
ᇞ 13
ᇞ 572 14.8%
671 113 87.8%
ᇞ 263
310
64 126.0%99
1.9%
1,196 14
876 350 1 100.4%
1,400 245 29 112.1%
261.8% 8
275
ᇞ 1,125 19.6%ᇞ 1,173 218
398 318 ᇞ 19 93.9%
176 170.7% 250
351
ᇞ 524 40.1%426
ᇞ 133 76.2%642
ᇞ 37 94.5%679
100.3%
9,663 ᇞ 205 97.9%
392 256.9% 250
298
ᇞ 99 75.0%373
291 455.7%23
560
82 155 171.3%
9,718
0
9,513
ᇞ 149 98.5%5,015 48 15
0
101.0%
104.9% 98.2%
ᇞ 64 95.4% 1,411
Depreciation 1,429
1,346
ᇞ 82 94.2%ᇞ 228 82.3% 1,288
Capital expenditures 1,505
1,059
ᇞ 445 70.4%ᇞ 117 97.0%
3,936 ᇞ 349 91.6%
ᇞ 1,219
遺伝子工学研究
3,819
4,1685,031
11
4,983 10 11License for use of trademarks
,
Depreciation ,
,
要約
借対照表
:Balance Sheets (Summary)資産の部
:Assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2008 FY2009 change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
Cash and deposits
手形及び売掛金
タ バ △ タ コ △ etcTakara Bio △5.8, Takara Korea Biomedical △7.4 etc.
価証券
Marketable securities
卸資産
Inventories
そ
他
繰延税金資産 (Deferred tax assets) + etcOther current assets
倒引当金
Allowance for doubtful accounts
固定資産
(Total fixed assets)
形固定資産
当期 形 無形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible assets
建物及び構築物
新規 得 +Buildings and structures N l h +10 5
Notes and accounts receivable-trade, net
25,676
25,417
258
8,932
8,653
278
4,814
5,659
ᇞ
845
7,555
7,310
245
3,287
3,176
111
1,133
725
407
ᇞ
46
ᇞ
108
61
17,441
19,871
ᇞ
2,430
11,754
12,356
ᇞ
601
3 913
3 759
154
Buildings and structures Newly purchases +10.5
機械装置及び運搬具
減価償却 △Machinery, equipment and vehicles Depreciation △13.4
土地
そ 他増減 △ 替差△ etcLand Other,net △18.6(Foreign currency exchange loss △9.6 etc.)
そ
他
Other property, plant and equipment
無形固定資産
Intangible fixed assets
投資そ
他
資産
Investments and other assets
投資
価証券
Investment securities
そ
他
Other assets
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
3,913
3,759
154
1,943
2,262
ᇞ
319
4,613
4,633
ᇞ
19
1,284
1,701
ᇞ
416
ᇞ
1,554
2,809
3,083
ᇞ
274
164
404
ᇞ
239
2,877
4,432
43,117
45,289
ᇞ
2,171
2,644
2,679
ᇞ
35
0
ᇞ
0
0
要約
借対照表
:Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2008 FY2009 change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
タ バ (Takara Bio) △ etcNotes and accounts payable-trade
短期借入金
Short-term loans payable
そ
他
Other current liabilities
固定負債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付引当金
Reserve for retirement benefits
そ
他
繰延税金負債 (Deferred tax liabilities) △ etcOther non-current liabilities
負債合計
Total liabilities
資本金
Capital stock
資本剰余金
Capital surplus
利益剰余金
Retained earnings
自己株式
Treasury stock
株主資本
(Total owner's equity)
そ
他
価証券評価差額金
繰延
ッ
損益
替換算調整勘定
評価
換算差額等
少数株主持分
(Minority interests)
純資産合計
Net assets
負債純資産合計
Total liabilities and net assets
0
0
-
26,967
18
2,364
2,035
329
5,968
6,180
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
(Total valuation and translation adjustments)
989
ᇞ
1,223
ᇞ
1,332
700
ᇞ
2,033
ᇞ
2,213
ᇞ
212
9,040
9,022
18
26,949
728
1,115
ᇞ
387
455
501
ᇞ
45
993
922
71
2,312
2,374
ᇞ
62
2,178
2,539
ᇞ
361
45
44
0
3,789
3,641
148
1,432
1,221
211
38,373
38,007
365
0
0
-
ᇞ
179
109
289
0
110
ᇞ
110
43,117
45,289
ᇞ
2,171
37,149
39,108
ᇞ
1,958
事業
種類
セ
メン
情報
:Industry Segments Information売
高及び営業損益
:Sales and Operating Income
売上高
:Total sales 百万 :Millions of Yen増減 比
change %
酒類
食品
Alcoholic Beverages and Foods178,277
176,626
174,143
-
-
- -バ
Biomedical13,685
16,534
20,982
-
-
- -そ
他
Other10,890
11,975
11,148
-
-
- -消去又
全社
Eliminations/Corporateᇞ
7,494
ᇞ
9,017
ᇞ
7,738
-
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
168,040
157,638
160,123
2,484 101.6%バ
Biomedical-
-
20,982
20,278
18,913
ᇞ 1,364 93.3%物流
Transportation-
-
14,415
16,685
17,004
319 101.9%そ
他
Other-
-
11,148
12,729
11,886
ᇞ 842 93.4%消去又
全社
Eliminations/Corporate-
-
ᇞ
16,050
ᇞ
15,453
ᇞ
15,137
315 -連結
Consolidated195,359
196,119
198,535
191,878
192,790
912 100.5%営業費用
:Operating expenses酒類
食品
Alcoholic Beverages and Foods169,632
169,020
165,986
-
-
- -バ
Biomedical14,762
18,010
21,187
-
-
- -そ
他
Other10,256
11,282
10,663
-
-
- -消去又
全社
Eliminations/Corporateᇞ
6,694
ᇞ
8,118
ᇞ
6,961
-
-
- -郤賦 能営業費用Unallocated operating expenses 925 983 978 - - - -
酒類
調味料
Alcoholic Beverages and Seasonings-
-
160,342
149,450
151,641
2,191 101.5%バ
Biomedical-
-
21,187
19,707
18,476
ᇞ 1,231 93.8%物流
Transportation-
-
13,960
16,236
16,521
284 101.8%そ
他
Other-
-
10,663
12,705
11,768
ᇞ 936 92.6%消去又
全社
Eliminations/Corporate-
-
ᇞ
15,278
ᇞ
14,728
ᇞ
14,468
259 -郤賦 能営業費用Unallocated operating expenses - - 978 956 868 ᇞ 87 90.8%
連結
Consolidated187,956
190,194
190,875
183,371
183,939
567 100.3%営業利益
△:損失
:Operating income(△:loss)酒類
食品
Alcoholic Beverages and Foods8,644
7,605
8,157
-
-
- -バ
Biomedicalᇞ
1,076
ᇞ
1,476
ᇞ
205
-
-
- -そ
他
Other634
693
485
-
-
- -消去又
全社
Eliminations/Corporateᇞ
799
ᇞ
898
ᇞ
777
-
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
7,697
8,187
8,481
293 103.6%バ
Biomedical-
-
ᇞ
205
570
437
ᇞ 132 76.7%物流
Transportation-
-
455
448
482
34 107.6%そ
他
Other-
-
485
23
117
94 496.0%消去又
全社
Eliminations/Corporate-
-
ᇞ
772
ᇞ
724
ᇞ
668
56 -連結
Consolidated7,402
5,924
7,660
8,506
8,851
345 104.1%前期対比 Change from FY2008
FY2005 FY2006 FY2007 FY2008 FY2009
成
期
成
期
成
期
成
期
成
期
資産
減価償却費
減損損失及び資本的支出
:Assets, Depreciation, Impairment loss and Capital Expenditures
資産
:Assets 百万 :Millions of Yen増減 比
change %
酒類
食品
Alcoholic Beverages and Foods115,428
116,533
119,637
-
-
- -バ
Biomedical37,427
44,443
45,539
-
-
- -そ
他
Other7,351
11,732
11,759
-
-
- -消去又
全社
Eliminations/Corporate30,566
39,757
36,456
-
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
115,555
112,941
109,859
ᇞ 3,082 97.3%バ
Biomedical-
-
45,539
45,289
43,117
ᇞ 2,171 95.2%物流
Transportation-
-
5,745
5,561
6,073
511 109.2%そ
他
Other-
-
11,759
11,068
11,621
553 105.0%消去又
全社
Eliminations/Corporate-
-
34,793
32,983
20,120
ᇞ 12,863 61.0%連結
Consolidated190,773
212,466
213,393
207,843
190,792
ᇞ 17,051 91.8%減価償却費
:Depreciation酒類
食品
Alcoholic Beverages and Foods4,127
4,275
3,958
-
-
- -バ
Biomedical1,304
1,477
1,608
-
-
- -そ
他
Other137
120
115
-
-
- -消去又
全社
Eliminations/Corporate58
36
27
-
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
3,719
3,596
3,299
ᇞ 296 91.7%バ
Biomedical-
-
1,608
1,429
1,346
ᇞ 82 94.2%流
成
期
成
期
前期対比 Change from FY2008
FY2005 FY2006 FY2007 FY2008 FY2009
成
期
成
期
成
期
物流
Transportation-
-
238
294
289
ᇞ 5 98.2%そ
他
Other-
-
115
114
121
7 106.6%消去又
全社
Eliminations/Corporate-
-
27
21
18
ᇞ 3 83.1%連結
Consolidated5,628
5,910
5,710
5,455
5,074
ᇞ 381 93.0%減損損失
:Impairment loss酒類
食品
Alcoholic Beverages and Foods0
0
0
-
-
- -バ
Biomedical0
0
0
-
-
- -そ
他
Other0
0
0
-
-
- -消去又
全社
Eliminations/Corporate3,469
0
0
-
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
0
0
22
22 -バ
Biomedical-
-
0
0
0
- -物流
Transportation-
-
0
0
0
- -そ
他
Other-
-
0
0
0
- -消去又
全社
Eliminations/Corporate-
-
0
170
207
36 121.3%連結
Consolidated3,469
0
0
170
229
58 134.2%資本的支出
:Capital Expenditures酒類
食品
Alcoholic Beverages and Foods4,378
4,253
2,573
-
-
- -バ
Biomedical2,086
1,264
952
-
-
- -そ
他
Other44
110
96
-
-
- -消去又
全社
Eliminations/Corporate1
5
ᇞ
4
-
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
2,179
1,764
1,941
176 110.0%バ
Biomedical-
-
952
1,505
1,059
ᇞ 445 70.4%物流
Transportation-
-
394
465
438
ᇞ 26 94.2%そ
他
Other-
-
96
116
140
23 120.5%消去又
全社
Eliminations/Corporate-
-
ᇞ
4
0
36
36 -連結
Consolidated6,511
5,633
3,617
3,852
3,616
ᇞ 235 93.9%成
期 業績
想
:Financial forecast for the year ending March 31, 2010宝ホ
ン
連結
:Takara Holdings Inc. ‐Consolidated‐百万 :Millions of Yen
成
成
成 成期実績
期
想
中間期実績 中間期 想FY2009 FY2010 増減 比 FY2009(1
st
Half)FY2010(1st Half)
増減 比
Actual Forecast change % Actual Forecast change %
宝酒造
タ
バ
そ
他
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
研究開発費
管理費
そ
他
販売費及び一般管理費
宝酒造
前期対比
Change from FY2009(1st
Half)
98.6%
45
102.6% 99.6%
ᇞ 978
97.9% 100.6%
3,300
1,900
14,800
821,800
98.9% 92.1% 93.2% 169,301 18,913ᇞ 164
4,575
4,630
170,200
18,370
ᇞ 337
ᇞ 607
ᇞ 32
80,637 8,927
80,300
8,320
101.2% 898ᇞ 543
2,412 100.5%
97.1%
2,380
ᇞ 1,177 98.8% 199
75,800
56,200
192,79091,000
34,800
34,600117,400
91,978 57,377 100.2% 409 3,217 2,064 102.2% 6,8513,800
21,200
193,200
544,100
30,800
7,000
148ᇞ 1,449 118,849
73,941 1,858 102.5%
101.0% 103.7% 113.6% 100.3% 42 456 70 4,057 29,707 3,343 21,129 103.4% 100.4% 112.3% 648 102.0% 31,851 487 196
10,700
32,500
2,100
14,312 1,603 10,654 65,090 1,092 102.8% 85.0%2,471 ᇞ 371
Change from FY2009 前期対比
7,500
66,900
34 100.5% Takara Shuzo Group
Cost of sales Gross profit Other,net Takara Bio Group
Net sales
Research and development Transportation and storage
Other,net Advertising
販売
進費
販売
進引当金繰入
7,465
1,809 Sales promotion and allowance for s.p.
SG&A expenses Takara Shuzo Group
タ
バ
そ
他
営業利益
△:損失
利息
郤当金
そ
他営業外収益
Other,net
営業外収益
支払利息
そ
他営業外費用
Other,net
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
18 100.7%
2,481
2,500
1,691
Capital expenditures 3,616
4,453
836 123.1%Depreciation 5,074
5,200
125 102.5%-
- -ᇞ 108
ᇞ 67
ᇞ 6 98.0%
ᇞ 261 -
ᇞ 37 90.6%
ᇞ 449
52.9%
ᇞ 267
87.0%
-
ᇞ 1,492 44.6% 2,692
ᇞ
166
1,200
366
2,400
408 167 5,6391,083
800
ᇞ 283 73.8%2,400
300
0
0
606
600
ᇞ 6 98.9%0
9,000
298 103.4%ᇞ 1,774
3,209
ᇞ 1,002 1,582
8,900
706 108.6%69.4% 576
5,000
ᇞ 639 88.7%626
100
ᇞ 526 16.0%306 403
567
1,233
700
ᇞ 533 56.8%469 8,851
73.4%
59.6%
ᇞ 40 -
ᇞ 125
83.7% 2,749
300
100
ᇞ 469
769
2,300
400
8,7018,900
300
261 771600
312
200
64.1%ᇞ 171
ᇞ 112
77.8%
2,758
0
ᇞ 769 - 921 -1,277
8,193
3,800
1,498 165.1% 4,075100
ᇞ 1,177 7.8%465
38 109.0%426
959
935
48
Minority interests in net income △:loss Income(△:loss) before income taxes and minority interests
Deferred income taxes
100
ᇞ 152 39.6% 252ᇞ 809 74.8%
ᇞ 36 -
ᇞ 63
719 223.9%
ᇞ
100
1,300
ᇞ 24 97.5%
Operating income(△:loss)
ᇞ 921
100.6%
ᇞ 176
ᇞ 358
Net income(△:loss) Takara Bio Group Other,net
当期純利益
△:損失
Extraordinary gain
税金等調整前当期純利益
△:損失
Extraordinary loss
Current income taxes Non-operating income
Non-operating expenses
Ordinary income(△:loss)
Interest income Dividends income
Interest and discounts expenses
宝酒造
:Takara Shuzo Group百万 :Millions of Yen
成
成
成 成期実績
期
想
中間期実績 中間期 想FY2009 FY2010 増減 比 FY2009(1
st
Half) FY2010(1st Half) 増減 比
Actual Forecast change % Actual Forecast change %
焼郥
清酒
ソフ
コ
飲料
そ
他酒類
本
そ
他調味料
原料用
コ
等
そ
他
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
Shochu
Cost of sales Gross profit Light-alcohol refreshers Sake Net sales Other liquors Raw alcohol Other seasonings Other Hon Mirin
Transportation and storage Advertising
販売
進費
販売
進引当金繰入
Sales promotion and allowance for s p
102.2% 89.7% 103.5% 2,935 1,895 13,617 64
1,700
ᇞ 195482
14,100
102.3%
51,628
3,726
28,371 1,128 104.0%
3,800
73 102.0%90.8%
10,997 ᇞ 636 88.6%
62,174 191 100.7%
169,301 80,637 2,783 107,127 108.8%
2,540
106.1% 99.5%ᇞ 527
ᇞ 867 92.4% 11,400 100.5%
170,200
10,532
898 29,008 98.5%11,158
76,783 22,561 20,569 92.8%10,200
21,236
2,047ᇞ 758
666
78,830
21,802
102.7% 96.6%38,306
7,722
8,055 706ᇞ 332
15,615
ᇞ 72 99.5% 15,688ᇞ 797
4,930
7,406
ᇞ 1095,763
317 105.8%5,445
5,856
6,218
3622,952
5,316
80,300
29,200
51,100
6,276
6,400
123 102.0%29,500
106,600
63,600
1,425ᇞ 540
206
3,000
102.2%
99.0% 99.6%
ᇞ 528
前期対比 前期対比
Change from FY2009 Change from FY2009(1st Half) 169 5,857 2,334 106.2% 5,566 95.9% 235
ᇞ 337
103.2% 10,923
7,516
101.9% 37,600
研究開発費
管理費
そ
他
販売費及び一般管理費
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss Income(△:loss) before income taxes and minority interests
Deferred income taxes
-
124 ᇞ 124
0
ᇞ 254 -21 Non-operating income
Non-operating expenses
Ordinary income(△:loss)
Other,net
Operating income(△:loss) Research and development
Sales promotion and allowance for s.p.
-
ᇞ 177 36.0%
77.9% 2,822
ᇞ 34
1,000
ᇞ 269 78.8% 1,3037,465 ᇞ 371
ᇞ 348
274
ᇞ 136
85.0% 2,471
50.5% 197
7,500
34 100.5%72.8%
68.7%
7,600
50 100.7%84.0%
1,429
1,200
2,200
86.3%2,548
0
ᇞ 223436 ᇞ 97
7,549
-
0
-223 ᇞ 390
2,200
7,495 ᇞ 622
390
0
ᇞ 115 115100
4,200
452 112.1%400
ᇞ 121 76.8%300
3,747 ᇞ 229
521 ᇞ 74
277
200
100
3,300
ᇞ 193 94.5% 3,471254
0
7,500
4 100.1%102.1% 26,537 102.3% 117.0% 170 7,918
56,100
1,390 102.5% 54,709 29 181 45 20 56216,000
200
354 15,979 112.8% 100.1%ᇞ 51 97.1% 1,751
Depreciation 3,588
3,600
11 100.3%1,700
- -
1,015
Capital expenditures 2,379
2,664
284 112.0%-
27,100
2,100
8,100
400
タ
バ
:Takara Bio Group百万 :Millions of Yen
成
成
成 成期実績
期
想
中間期実績 中間期 想FY2009 FY2010 増減 比 FY2009(1
st
Half)FY2010(1st Half) 増減 比
Actual Forecast change % Actual Forecast change %
研究用試薬
理化学機器
託
そ
他フ
ン
遺伝子工学研究
計
遺伝子医療
医食品バ
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
研究開発費
管理費
そ
他
115.6% 2,014
294
313
19 106.7%97.1%
1,068
3,441
4,950
50
ᇞ 608
ᇞ 103
89.2% 5,631 1,147 165 126 113.3% 951
299
133 180.3%2,328
314 11,906 2,177 2,649 94.1%2,487
ᇞ 821
ᇞ 8
ᇞ 162
15,741
ᇞ 99111,085
2,168
93.1% 99.6% 91.7% 90.9%9,940 4 100.1%
18,913
16,733 ᇞ 805 89.8%
ᇞ 92
ᇞ 607
8,973 ᇞ 894 90.0%
ᇞ 543
18,370
1,118 4,309 93.9% 7,897 71 190.7% 78 32 85.8% 93.2% 4,6188,079
10,290
350 103.5%ᇞ 612
8,927 50 1,149 2,976 5,042 99.7% 93.0% 115.6% 0
ᇞ 80
465 129.7% 97.6% 89.9% 95.3% 113.6% 109 25 0
ᇞ 58
194
ᇞ 121
1,430
2,602 98.2%
ᇞ 92
Transportation and storage
Other net Advertising Sales promotion
販売
進費
Research and development Research reagents
Cost of sales Gross profit
Contracted service and other Scientific instruments
Net sales
Genetic engineering research segment Gene medicine segment
Agribio segment
8,320
3,696
4,623
142
25
517
前期対比 前期対比
Change from FY2009 Change from FY2009(1st
Half)
1,624
2,480
5765,022
1,043
1,026
7,092
149
1,078
販売費及び一般管理費
遺伝子医療
医食品バ
共通
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
ᇞ
1,580
ᇞ 339 -4,154
16 102.5% 664
Depreciation 1,346
1,464
118 108.8%Capital expenditures
-
681
1,706
646 161.0%1,059 593 - -
335 108.8% 3,819
642
360
ᇞ 282 56.0% ᇞ 326 81 -9,825
4,744 101.0%1,678
88 105.5%1,590 103.3%
373
45 9,513
600
248 170.6%351 5
426
298
ᇞ 1,240 ᇞ 191
ᇞ 575
ᇞ 34 -
ᇞ 1,576
-
ᇞ 103
465
38 109.0%62
ᇞ 311 16.6% 114 11.5%ᇞ 54 60.1% 136
197
ᇞ 101 66.0%ᇞ 101
82
13
0
ᇞ 23 --
ᇞ 313
ᇞ 856 ᇞ 141
579
275 219 ᇞ 210 3.9%
ᇞ 8 -
8
20
ᇞ 254 7.6%23
0
8
ᇞ
106
0
ᇞ 3 -479 581.0% 99
765 -
310
3
-
ᇞ 543
49 -
219
ᇞ
798
-
1
ᇞ 360
ᇞ
311
13 -
ᇞ 811
207
127
0
ᇞ
498
77 -ᇞ
1,610
Non-operating income Non-operating expenses
Ordinary income(△:loss)
Other,net
Operating income(△:loss) Gene medicine segment
Genetic engineering research segment
遺伝子工学研究
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss Income(△:loss) before income taxes and minority interests Agribio segment
Eliminations/Corporate
138
ᇞ
734
ᇞ
166
ᇞ
97
ᇞ
244
4,790
1283.3% 152
ᇞ 1
ᇞ 40 -
ᇞ 125
311